tiprankstipranks
Trending News
More News >
Phathom Pharmaceuticals (PHAT)
NASDAQ:PHAT
US Market

Phathom Pharmaceuticals (PHAT) Income Statement

Compare
545 Followers

Phathom Pharmaceuticals Income Statement

Last quarter (Q3 2025), Phathom Pharmaceuticals's total revenue was $49.50M, an increase of 202.74% from the same quarter last year. In Q3, Phathom Pharmaceuticals's net income was $-29.97M. See Phathom Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 55.25M$ 682.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 47.28M$ 515.00K$ -620.00K$ -521.00K$ -300.00K
Operating Expenses
$ 324.75M$ 167.83M$ 171.82M$ 134.56M$ 125.36M
Depreciation and Amortization
$ 795.00K$ 575.00K$ 620.00K$ 521.00K$ 300.00K
EBITDA
$ -261.52M$ -159.05M$ -169.80M$ -136.57M$ -124.19M
Operating Income
$ -277.47M$ -167.31M$ -172.44M$ -135.08M$ -125.67M
Other Income/Expenses
$ -56.86M$ -34.28M$ -25.28M$ -8.80M$ -3.40M
Pretax Income
$ -334.33M$ -201.59M$ -197.72M$ -143.88M$ -129.07M
Net Income
$ -334.33M$ -201.59M$ -197.72M$ -143.88M$ -129.07M
Per Share Metrics
Basic EPS
$ -5.29$ -3.93$ -5.70$ -4.00$ -4.01
Diluted EPS
$ -5.29$ -3.93$ -5.70$ -4.00$ -4.01
Weighted Average Shares Outstanding
63.18M 51.29M 39.12M 37.00M 33.23M
Weighted Average Shares Outstanding (Diluted)
63.18M 51.29M 39.12M 37.00M 33.23M
Currency in USD

Phathom Pharmaceuticals Earnings and Revenue History